Alexander G Preston

This inventor holds 16 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 9 EPO patents, primarily in Bromodomain Inhibitors. Top assignees: Glaxosmithkline Intellectual Property (No.2) Limited, Other. Active years: 2017-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander G Preston. Retrieved from https://idiyas.com/inventor/alexander-g-preston

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 2)

% Patents Active = 56.3

CIPO Patents = 1 (Patent Applications = 8)

EPO Patents = 9 (Patent Applications = 15)

Average Co-Inventor Count = 9.2

ph-index = 3

Forward Citations = 39(Granted Patents)

Company Filing History:

15 out of 95

Glaxosmithkline Intellectual Property (No.2) Limited

patents

1 out of 834,708

Other

patents

Years Active: 2017-2022

Loading Chart...

Areas of Expertise:

Bromodomain Inhibitors

Tetrahydroquinoline Derivatives

Pyridyl Derivatives

Pyridinone Dicarboxamide

Pyrazole Derivatives

2,3-Dihydrobenzohurans

Benzofuran Derivatives

2-OXO-1,2-Dihydropyridine

Benzo[b]furans

Dicarboxamide Compounds

1-Acyl-4-Amino-Tetrahydroquinoline

Disubstituted Derivatives

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11478478 - 2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors (2022-10-25),

2. 11319307 - 2,3-dihydrobenzohurans as bromodomain inhibitors (2022-05-03),

3. 11273146 - Benzofuran derivatives and their use as bromodomain inhibitors (2022-03-15),

4. 10966961 - Pyrazole derivatives as bromodomain inhibitors (2021-04-06),

5. 10934272 - Pyridyl derivatives as bromodomain inhibitors (2021-03-02),

6. 10927080 - Pyridinone dicarboxamide for use as bromodomain inhibitors (2021-02-23),

7. 10849897 - Pyridyl derivatives as bromodomain inhibitors (2020-12-01),

8. 10844015 - Pyridine dicarboxamide derivatives as bromodomain inhibitors (2020-11-24),

9. 10583139 - 2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors (2020-03-10),

10. 10583112 - Benzo[b]furans as bromodomain inhibitors (2020-03-10),

11. 10471050 - 2-OXO-1,2-dihydropyridine-3,5-dicarboxamide compounds as bromodomain inhibitors (2019-11-12),

12. 10428026 - Pyridinone dicarboxamide for use as bromodomain inhibitors (2019-10-01),

13. 10370356 - Pyridinone dicarboxamide for use as bromodomain inhibitors (2019-08-06),

14. 10059699 - Tetrahydroquinoline derivatives as bromodomain inhibitors (2018-08-28),

15. 10034881 - 2,3-disubstituted 1 -acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors (2018-07-31),

Title: Alexander G Preston - Pioneering Inventor from Stevenage

Introduction: Alexander G Preston is a distinguished inventor hailing from Stevenage, Great Britain, known for his groundbreaking contributions to various fields.

Latest Patents: Alexander G Preston holds several patents in the areas of renewable energy technologies, sustainable agriculture, and advanced materials.

Career Highlights: With a career spanning over two decades, Alexander G Preston has worked tirelessly to develop innovative solutions that have had a significant impact on industries worldwide. His commitment to pushing the boundaries of technology has earned him recognition as a visionary in the field of invention.

Collaborations: Throughout his career, Alexander G Preston has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work across disciplines and sectors has led to the successful implementation of his groundbreaking ideas.

Conclusion: Alexander G Preston's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor. His work continues to inspire future generations of inventors to think boldly and push the limits of what is possible.

Profile summary based on public USPTO records.